Ignite Creation Date:
2025-12-24 @ 3:33 PM
Ignite Modification Date:
2026-02-01 @ 5:37 PM
Study NCT ID:
NCT01748292
Status:
COMPLETED
Last Update Posted:
2019-06-04
First Post:
2012-12-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
Sponsor:
Charles C Wykoff, PhD, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ML28513
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |